All Stories

  1. Long-term outcomes in people with CF lacking FEV1 response to elexacaftor/tezacaftor/ivacaftor therapy
  2. Nasal potential difference in young children is feasible - Report from a national referral center
  3. Pulmonary function tests in infants following SARS-CoV-2 infection
  4. Bi-allelic LAMP3 variants in childhood interstitial lung disease: a surfactant-related disease
  5. Infant Pulmonary Function Testing in Pediatric Diffuse Parenchymal Lung Disease
  6. The association between low birth weight and pulmonary function in infants
  7. Novel lamp3 gene mutation associated with variable clinical presentation of interstitial lung disease
  8. Long-term outcomes in people with CF lacking early spirometry response to elexacaftor/tezacaftor/ivacaftor therapy
  9. Unbiased phenotype and genotype matching maximizes gene discovery and diagnostic yield
  10. The hidden highway: A forgotten complication of oropharyngeal infection in children
  11. Changes in Sleep in Children and Adults with Cystic Fibrosis and Primary Ciliary Dyskinesia over Time and after CFTR Modulator Therapy
  12. Pulmonary Function Tests in Infants Following SARS-CoV-2 Infection
  13. The long-term respiratory effect of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
  14. Platelet count and risk of severe illness in hospitalised children with Influenza‐Like illness
  15. Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators
  16. The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study
  17. Infant pulmonary function tests in individuals with Down syndrome
  18. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis‐related diabetes
  19. Pediatric admissions due to respiratory diseases during the COVID-19 pandemic
  20. The clinical significance of thrombocytosis in children with viral respiratory tract infections
  21. Variation in the pattern of childhood respiratory viral infections during the COVID-19 pandemic
  22. Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis
  23. Persistent hypoxaemia and a headache in a previously healthy 11-year-old girl
  24. Ethical Dilemma
  25. Infant Pulmonary Function Tests in Individuals with Down Syndrome
  26. Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis
  27. A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis
  28. The Use of Infant Pulmonary Function Tests in the Diagnosis of Neuroendocrine Cell Hyperplasia of Infancy
  29. Sleep in children with cystic fibrosis: More under the covers
  30. Betamethasone versus dexamethasone for inpatient preschool wheezing—A case‐control study
  31. Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia
  32. Whole Exome Sequencing Accuracy in the Diagnosis of Primary Ciliary Dyskinesia
  33. Reply to Turnbull et al. and to Hulme et al.
  34. Structural determinants of long-term functional outcomes in young children with cystic fibrosis
  35. Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis
  36. Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis
  37. MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease
  38. Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study
  39. Predicting disease progression in cystic fibrosis
  40. Side effects of medications used to treat childhood interstitial lung disease
  41. Oropharyngeal swabs not useful in young children with CF
  42. A quality improvement intervention to reduce emergency department radiography for bronchiolitis
  43. Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia
  44. Respiratory Hospitalizations and Rehospitalizations in Infants Born Late Preterm
  45. Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis
  46. Food Safety Crisis Management-A Comparison between Germany and the Netherlands
  47. Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease
  48. Treatment of cystic fibrosis in low-income countries
  49. The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia
  50. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy
  51. Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity
  52. Neurological complications and pandemic influenza A (H1N1) virus infection
  53. Functional architecture of the mammalian striatum: Mouse vascular and striosome organization and their anatomic relationships